( ARTG ) Prevention of skeletal related events in patients with multiple myeloma and in patients with bone metastases from solid tumours.,Treatment of giant cell tumour of bone in adults or skeletally mature adolescents that is recurrent, or unresectable, or resectable but associated with severe morbidity.,Treatment of hypercalcaemia of malignancy that is refractory to intravenou

HealthdirectFree Australian health advice you can count on.: INJECTION 120 mg/1.7mL

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

• Caution should be exercised in patients with history of kidney impairment, anemia, low blood calcium, any allergy, who are taking other medications, thyroid or kidney disease, infection, during pregnancy and breastfeeding. • In some patients, this medication may cause jawbone problems. ♦ Patient may develop Osteonecrosis of the Jaw (ONJ) with the following symptom: gum lesion

OTC

HealthdirectFree Australian health advice you can count on.

120 mg/1.7mL, Injection

INN: DENOSUMAB

Available in:

🇬🇧

Form

INJECTION

Dosage

120 mg/1.7mL

Route

SUBCUTANEOUS

Storage

—

About This Product

Manufacturer

Sandoz Inc

ATC Code

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.